Difference between revisions of "MRE Biomarker Ctte"
Jump to navigation
Jump to search
| Line 1: | Line 1: | ||
:Co-chairs: Richard L. Ehman, MD; Patricia Cole, PhD, MD | :Co-chairs: Richard L. Ehman, MD; Patricia Cole, PhD, MD | ||
:RSNA Staff Support: Susan Stanfa | :RSNA Staff Support: Susan Stanfa | ||
| − | * [ | + | * [https://docs.google.com/spreadsheets/d/e/2PACX-1vRXlDgOiADuCP3e9iHApSt4Z3zpel94OJN12IEQY8C4OT4u4LiiNnp9EWBP5FnCAgDL-YMe-m1NjasH/pubhtml?gid=1930876020&single=true Roster] |
Revision as of 17:04, 30 July 2020
- Co-chairs: Richard L. Ehman, MD; Patricia Cole, PhD, MD
- RSNA Staff Support: Susan Stanfa
Project Snapshot
The MRE Biomarker Committee seeks to develop a quantitative Profile for MRE.
MRE Profile to be data-driven:
- focusing on the characterization of bias and precision in MRE measurement targets for achieving these measurements
- focusing on issues important to specific reproducibility
Meetings
Approved call summaries:
Note: The last meeting of this group was held on January 23, 2020; notes are posted after they are approved by the MRE BC during the following t-con
MRE Profile Development
- MR Elastography of the Liver 2018-05-02
- MRE Profile, Draft: July 28, 2017
- MRE Profile, Initial Draft: July 6, 2017